Gastroparesis
1 paper1 finding
- Humans1
Associations
1GLP-1 receptor agonists
upin humans1
1 study
GLP-1 receptor agonists
upin humans1
GLP-1 receptor agonists raise the risk of gastroparesis in humans.
Humansversus DPP-4i in T2D with BMI < 27 kg/m2
Diabetes, obesity & metabolism25 Aug 2026
Trial sponsors
1 trialPhase 469 people
3 trialsPhase 259 people
1 trialEarly phase 114 people
1 trialEarly phase 110 people
1 trial60 people
Latest
6 in 12 monthsDiabetes, Obesity & Metabolism
Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m²: A Target Trial Emulation
Cohort study of 8,969 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Tirzepatide vs. Semaglutide and the Risk of Incident Gastroparesis: A Propensity-Matched Analysis of 828,426 Patients
Study in peopleInterventions
AHA Scientific Sessions 2025 Abstract
Early GLP-1 Receptor Agonist Initiation Reduces Major Cardiac and Renal Events in Older Adults with Type 2 Diabetes Without Prior Cardiovascular or Renal Disease: A Target Trial Emulation
Study in peopleInterventions
AHA Scientific Sessions 2025 Abstract
Evaluating Procedural Safety and Outcomes In GLP-1 Exposed Patients Undergoing TEE
Study in peoplePopulations
AHA Scientific Sessions 2025 Abstract
Impact of GLP-1 Analog Use on Clinical Outcomes Following Bariatric Surgery: A Propensity-Matched Retrospective Cohort Study
Study in peopleInterventions
AHA Scientific Sessions 2025 Abstract
GLP-1 Receptor Agonists Lower Readmission Rates Without Impacting Mortality After CABG in Adults with Congenital Heart Disease
Study in peopleInterventions
ADA Scientific Sessions 2025 Abstract
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Motility-Related Gastrointestinal Adverse Events—A Cohort Study
Study in peopleInterventions
ADA Scientific Sessions 2025 Abstract
All-Cause Mortality and GI Adverse Effects in Adults with Type 1 Diabetes (T1D) on GLP-1RA
Study in peopleInterventions